Human xylosyltransferase-I - A new marker for myofibroblast differentiation in skin fibrosis

Biochemical and Biophysical Research Communications

Volumn 436, Issue 3, 2013, Pages 449-454

  Faust, I ^a   Roch, C ^a   Kuhn, J ^a   Prante, C ^a   Knabbe, C ^a   Hendig, D ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

Biomarker; Dermal fibroblast; Fibrogenesis; Myofibroblast; Skin fibrosis; Xylosyltransferase

Indexed keywords

MESSENGER RNA; TRANSFERASE; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 1; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG; XYLOSYLTRANSFERASE I;

ARTICLE; BIOSYNTHESIS; CELL DENSITY; CELL DIFFERENTIATION; CONTROLLED STUDY; ENZYME ACTIVITY; FIBROBLAST; FIBROGENESIS; HUMAN; HUMAN CELL; HYPERTROPHIC SCAR; IMMUNOHISTOCHEMISTRY; MYOFIBROBLAST; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEOGLYCAN SYNTHESIS; SIGNAL TRANSDUCTION; SKIN FIBROSIS;

Α-SMA/ACTA2; ALK5; ALPHA-SMOOTH MUSCLE ACTIN; BIOMARKER; DERMAL FIBROBLAST; DISINTEGRATIONS PER MINUTE; DPM; FIBROGENESIS; GAG; GLYCOSAMINOGLYCAN; MYOFIBROBLAST; NHDF; NORMAL HUMAN DERMAL FIBROBLAST; QUANTITATIVE REAL-TIME PCR; RT-PCR; SKIN FIBROSIS; TGF-Β1; TRANSFORMING GROWTH FACTOR-Β RECEPTOR I; TRANSFORMING GROWTH FACTOR-Β1; XT/XYLT; XYLOSYLTRANSFERASE;

ACTINS; BENZAMIDES; BIOLOGICAL MARKERS; CELL DIFFERENTIATION; DIOXOLES; ENZYME ACTIVATION; FIBROSIS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; MYOFIBROBLASTS; PENTOSYLTRANSFERASES; PROTEIN-SERINE-THREONINE KINASES; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; RNA, MESSENGER; SKIN; TIME FACTORS; TRANSFORMING GROWTH FACTOR BETA1; UP-REGULATION;

EID: 84879888709     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2013.05.125     Document Type: Article

References (34)

1. Skalli O., Schurch W., Seemayer T., Lagace R., Montandon D., Pittet B., Gabbiani G. Myofibroblasts from diverse pathologic settings are heterogeneous in their content of actin isoforms and intermediate filament proteins. Lab. Invest. 1989, 60:275-285.
2. Hinz B., Phan S.H., Thannickal V.J., Prunotto M., Desmouliere A., Varga J., De Wever O., Mareel M., Gabbiani G. Recent developments in myofibroblast biology: paradigms for connective tissue remodeling. Am. J. Pathol. 2012, 180:1340-1355.
3. Gabbiani G. The myofibroblast in wound healing and fibrocontractive diseases. J. Pathol. 2003, 200:500-503.
4. Darby I., Skalli O., Gabbiani G. Alpha-smooth muscle actin is transiently expressed by myofibroblasts during experimental wound healing. Lab. Invest. 1990, 63:21-29.
5. Desmouliere A., Geinoz A., Gabbiani F., Gabbiani G. Transforming growth factor-beta 1 induces alpha-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblasts. J. Cell Biol. 1993, 122:103-111.
6. Sarrazy V., Billet F., Micallef L., Coulomb B., Desmouliere A. Mechanisms of pathological scarring: role of myofibroblasts and current developments. Wound Repair Regen. 2011, 19(Suppl. 1):S10-S15.
7. Desmouliere A., Redard M., Darby I., Gabbiani G. Apoptosis mediates the decrease in cellularity during the transition between granulation tissue and scar. Am. J. Pathol. 1995, 146:56-66.
8. Arora P.D., Narani N., McCulloch C.A. The compliance of collagen gels regulates transforming growth factor-beta induction of alpha-smooth muscle actin in fibroblasts. Am. J. Pathol. 1999, 154:871-882.
9. Vaughan M.B., Howard E.W., Tomasek J.J. Transforming growth factor-beta1 promotes the morphological and functional differentiation of the myofibroblast. Exp. Cell Res. 2000, 257:180-189.
10. Hinz B., Gabbiani G., Chaponnier C. The NH2-terminal peptide of alpha-smooth muscle actin inhibits force generation by the myofibroblast in vitro and in vivo. J. Cell Biol. 2002, 157:657-663.
11. Douglass A., Wallace K., Koruth M., Barelle C., Porter A.J., Wright M.C. Targeting liver myofibroblasts: a novel approach in anti-fibrogenic therapy. Hepatol. Int. 2008, 2:405-415.
12. Ruiz-Ortega M., Rodriguez-Vita J., Sanchez-Lopez E., Carvajal G., Egido J. TGF-beta signaling in vascular fibrosis. Cardiovasc. Res. 2007, 74:196-206.
13. Varga J., Pasche B. Antitransforming growth factor-beta therapy in fibrosis: recent progress and implications for systemic sclerosis. Curr. Opin. Rheumatol. 2008, 20:720-728.
14. Götting C., Kuhn J., Zahn R., Brinkmann T., Kleesiek K. Molecular cloning and expression of human UDP-d-Xylose:proteoglycan core protein beta-d-xylosyltransferase and its first isoform XT-II. J. Mol. Biol. 2000, 304:517-528.
15. Pönighaus C., Ambrosius M., Casanova J.C., Prante C., Kuhn J., Esko J.D., Kleesiek K., Götting C. Human xylosyltransferase II is involved in the biosynthesis of the uniform tetrasaccharide linkage region in chondroitin sulfate and heparan sulfate proteoglycans. J. Biol. Chem. 2007, 282:5201-5206.
16. Götting C., Kuhn J., Kleesiek K. Human xylosyltransferases in health and disease. Cell. Mol. Life Sci. 2007, 64:1498-1517.
17. Kuhn J., Gressner O.A., Gotting C., Gressner A.M., Kleesiek K. Increased serum xylosyltransferase activity in patients with liver fibrosis. Clin. Chim. Acta 2009, 409:123-126.
18. Götting C., Sollberg S., Kuhn J., Weilke C., Huerkamp C., Brinkmann T., Krieg T., Kleesiek K. Serum xylosyltransferase: a new biochemical marker of the sclerotic process in systemic sclerosis. J. Invest. Dermatol. 1999, 112:919-924.
19. Swann D.A., Garg H.G., Jung W., Hermann H. Studies on human scar tissue proteoglycans. J. Invest. Dermatol. 1985, 84:527-531.
20. Vandesompele J., De Preter K., Pattyn F., Poppe B., Van Roy N., De Paepe A., Speleman F. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol. 2002, 3. (RESEARCH0034).
21. Weilke C., Brinkmann T., Kleesiek K. Determination of xylosyltransferase activity in serum with recombinant human bikunin as acceptor. Clin. Chem. 1997, 43:45-51.
22. Brown B.C., McKenna S.P., Siddhi K., McGrouther D.A., Bayat A. The hidden cost of skin scars: quality of life after skin scarring. J. Plast. Reconstr. Aesthet. Surg. 2008, 61:1049-1058.
23. Moinzadeh P., Denton C.P., Abraham D., Ong V., Hunzelmann N., Eckes B., Krieg T. Biomarkers for skin involvement and fibrotic activity in scleroderma. J. Eur. Acad. Dermatol. Venereol. 2011, 26:267-276.
24. Ferguson M.W., O'Kane S. Scar-free healing: from embryonic mechanisms to adult therapeutic intervention. Philos. Trans. R. Soc. Lond. B Biol. Sci. 2004, 359:839-850.
25. Mak K., Manji A., Gallant-Behm C., Wiebe C., Hart D.A., Larjava H., Hakkinen L. Scarless healing of oral mucosa is characterized by faster resolution of inflammation and control of myofibroblast action compared to skin wounds in the red duroc pig model. J. Dermatol. Sci. 2009, 56:168-180.
26. Prante C., Milting H., Kassner A., Farr M., Ambrosius M., Schon S., Seidler D.G., Banayosy A.E., Korfer R., Kuhn J., Kleesiek K., Gotting C. Transforming growth factor beta1-regulated xylosyltransferase I activity in human cardiac fibroblasts and its impact for myocardial remodeling. J. Biol. Chem. 2007, 282:26441-26449.
27. de Gouville A.C., Huet S. Inhibition of ALK5 as a new approach to treat liver fibrotic diseases. Drug News Perspect. 2006, 19:85-90.
28. Dziedzic D., Wegrzyn G., Jakobkiewicz-Banecka J. Impairment of glycosaminoglycan synthesis in mucopolysaccharidosis type IIIA cells by using siRNA: a potential therapeutic approach for sanfilippo disease. Eur. J. Hum. Genet. 2010, 18:200-205.
29. Masur S.K., Dewal H.S., Dinh T.T., Erenburg I., Petridou S. Myofibroblasts differentiate from fibroblasts when plated at low density. Proc. Natl. Acad. Sci. U.S.A. 1996, 93:4219-4223.
30. Roch C., Kuhn J., Kleesiek K., Götting C. Differences in gene expression of human xylosyltransferases and determination of acceptor specificities for various proteoglycans. Biochem. Biophys. Res. Commun. 2009, 391:685-691.
31. Yamaguchi Y., Mann D.M., Ruoslahti E. Negative regulation of transforming growth factor-beta by the proteoglycan decorin. Nature 1990, 346:281-284.
32. Dabiri G., Campaner A., Morgan J.R., Van De Water L. A TGF-beta1-dependent autocrine loop regulates the structure of focal adhesions in hypertrophic scar fibroblasts. J. Invest. Dermatol. 2006, 126:963-970.
33. Chen Q., Sivakumar P., Barley C., Peters D.M., Gomes R.R., Farach-Carson M.C., Dallas S.L. Potential role for heparan sulfate proteoglycans in regulation of transforming growth factor-beta (TGF-beta) by modulating assembly of latent TGF-beta-binding protein-1. J. Biol. Chem. 2007, 282:26418-26430.
34. Susarla B.T., Laing E.D., Yu P., Katagiri Y., Geller H.M., Symes A.J. Smad proteins differentially regulate transforming growth factor-beta-mediated induction of chondroitin sulfate proteoglycans. J. Neurochem. 2011, 119:868-878.